Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 7
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Iasevoli, Felice Giordano, Sara Balletta, Raffaele Latte, Gianmarco Formato, Maria Vittoria Prinzivalli, Emiliano De Berardis, Domenico Tomasetti, Carmine and de Bartolomeis, Andrea 2016. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 65, p. 34.


    Mauri, Mauro Mauri, Massimo C. Adami, Marina Reggiardo, Giorgio and Giulio, Corrivetti 2015. Efficacy and tolerability of paliperidone ER in patients with unsatisfactorily controlled schizophrenia by other antipsychotics. International Clinical Psychopharmacology, Vol. 30, Issue. 6, p. 329.


    Nakhli, Jaafar Amamou, Badii Mlika, Salem Bouhlel, Saoussen Trifi, Marwan Nasr, Selma Ben El Kissi, Yousri and Ali, Béchir Ben Hadj 2015. Cultural translation and Tunisian validation of the Drug Attitude Inventory (DAI-30) in outpatients with schizophrenia. Comprehensive Psychiatry, Vol. 56, p. 69.


    Iasevoli, Felice Buonaguro, Elisabetta F. Marconi, Massimo Di Giovambattista, Emanuela Rapagnani, Maria Paola De Berardis, Domenico Martinotti, Giovanni Mazza, Monica Balletta, Raffaele Serroni, Nicola Di Giannantonio, Massimo de Bartolomeis, Andrea and Valchera, Alessandro 2014. Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study. ISRN Pharmacology, Vol. 2014, p. 1.


    Cortesi, Paolo A Mencacci, Claudio Luigi, Ferrannini Pirfo, Elvezio Berto, Patrizia Sturkenboom, Miriam CJM Lopes, Fabiana L Giustra, Maria G Mantovani, Lorenzo G and Scalone, Luciana 2013. Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study. BMC Psychiatry, Vol. 13, Issue. 1,


    Iasevoli, Felice Valchera, Alessandro Di Giovambattista, Emanuela Marconi, Massimo Rapagnani, Maria Paola De Berardis, Domenico Martinotti, Giovanni Fornaro, Michele Mazza, Monica Tomasetti, Carmine Buonaguro, Elisabetta F. Di Giannantonio, Massimo Perugi, Giulio and de Bartolomeis, Andrea 2013. Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. Journal of Affective Disorders, Vol. 151, Issue. 2, p. 540.


    Rossi, Alessandro Bagalà, Anna Del Curatolo, Vincenzo Scapati, Francesco Bernareggi, Micaela Maria and Giustra, Maria Grazia 2009. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder. Human Psychopharmacology: Clinical and Experimental, Vol. 24, Issue. 7, p. 574.


    ×
  • Currently known as: Epidemiology and Psychiatric Sciences Title history
    Epidemiologia e Psichiatria Sociale, Volume 10, Issue 2
  • June 2001, pp. 107-114

Subjective response to neuroleptic medication: a validation study of the Italian version of the Drug Attitude Inventory (DAI)

  • Alessandro Rossi, Luca Arduini (a1), Stefano De Cataldo (a2) and Paolo Stratta (a2)
  • DOI: http://dx.doi.org/10.1017/S1121189X00005182
  • Published online: 11 October 2011
Abstract
SUMMARY

Objective – Aim of the study was to investigate the psychometric properties of the Italian version of the Drug Attitude Inventory (DAI) by exploring its construct validity. Setting – 90 voluntary admitted patients with DSM III-R Schizophrenic (n.72) and Schizoaffective (n.18) disorders, age range between 18 and 50 years, treated with typical antipsychotics, able to participate in the study, were selected. Design – Exploratory factor analyses with alpha factoring and maximum–likelihood methods with Varimax Rotation were used to analyse DAI scores. Results – Extraction methods found 7 factors which explained 62.5% of the total variance. The first 2 factors could be labelled as “subjective response to treatment” construct and factors 3 to 7 as “attitude to medication” contruct. Conclusion – Although preliminarily, the Italian version of the DAI seems to maintain the original psychometric properties and it can be used easily to get a valid measurement of the patients' attitude to neuroleptic medication.

RIASSUNTO

Scopo – Verificare se la versione italiana della Drug Attitude Inventory mantiene le proprietà psicometriche del questionario originate attraverso una validazione di costrutto. Setting – Lo studio è stato condotto su 90 pazienti con diagnosi di Disturbo Schizofrenico (n=72) e Disturbo Schizoaffettivo (n=18) ammessi al ricovero volontario per un episodio indice di riesacerbazione psicotica, d'età compresa tra i 18 ed i 50 anni, in trattamento con farmaci antipsicotici tipici e cognitivamente in grado di comprendere e rispondere alle domande del questionario. Disegno – Sono state impiegate analisi fattoriali esplorative con i metodi d'estrazione alfa fattoriale e della massima verosimiglianza; successivamente è stato utilizzato il metodo di Rotazione Varimax. Risultati – I metodi d'estrazione utilizzati trovavano 7 fattori che spiegavano il 62.5% della varianza. I primi 2 fattori possono essere identificati nel costrutto di “risposta soggettiva al trattamento” ed i fattori da 3 a 7 nel costrutto di “atteggiamento nei confronti della terapia”. Conclusioni – Benché lo studio sia preliminare, la traduzione italiana dello strumento sembra mantenere le proprietà psicometriche della versione originale e può essere utilizzata nella pratica clinica per una valida misurazione deH'atteggiamento del paziente nei confronti del trattamento con farmaci antipsicotici.

Copyright
Corresponding author
Indirizzo per la corrispondenza: Professor A. Rossi, Dipartimento di Medicina Sperimentale, Università degli Studi de L'Aquila, Via Vetoio, Coppito 2, 67100 L'Aquila Fax: +39-0862-433.602 E-mail: rossi.aq@tin.it
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

A.G. Awad , L.N.P. Voruganti , R.J. Heslegrave & T.P. Hogan (1996). Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome. International Clinical Psychopharmacology 11, 5559.

P.E. Bebbington (1995). The content and context of compliance. International Clinical Psychopharmacology 9, Suppl. No. 5, 4150.

J.C. Day , P. Kinderman & R. Bentall (1998). A comparison of patients' and prescribers' beliefs about neuroleptic side-effects: prevalence, distress and causation. Ada Psychiatrica Scandinavica 97, 9397.

A. Healey , M. Knapp , J. Astin , J. Beecham , R. Kemp , J. Kirov & A David . (1998). Cost-effectiveness evaluation of compliance therapy for people with psychosis. British Journal of Psychiatry 172, 420424.

G.E. Hogarty , N.R. Schooler , R.F. Ulrich , F. Mussare , P. Ferro & E Herron . (1979). Fluphenazine and social therapy in the aftercare of schizophrenic patients: Relapse analysis of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Archives of General Psychiatry 36, 12831294.

S.K. Hoge , P.S. Appelbaum , T. Lawlor , J.C. Beck , R. Litman , A Greer ., T.G. Gutheil & E. Kaplan (1990). A prospective, multicenter study of patients' refusal of antipsychotic medication. Archives of General Psychiatry 47, 949956.

O. Kampman & K. Lehtinen (1999). Compliance in psychoses. Ada Psychiatrica Scandinavica 100, 167175.

R. Kemp & A. David (1996). Psychological predictors of insight and compliance in psychotic patients. British Journal of Psychiatry 169, 444450.

R. Kemp , P. Hayward , G. Applewhaite , B. Everitt & A. David (1996) Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal 312, 345349.

R. Kemp , G. Kirov , B. Everitt , P. Hayward & A. David (1998). Randomised controlled trial of compliance therapy. British Journal of Psychiatry 172, 413419.

Z.J. Lipowski (1977). The importance of body experience for psychiatry. Comprehensive Psychiatry 18, 473479.

P.R.A. May , T. Van Putten & C. Yale (1976). Predicting individual responses to drug treatment in schizophrenia: a test dose model. Journal of Nervous and Mental Disease 162, 177183.

P.R.A. May , T. Van Putten , D.J Jenden , C Yale , W.J. Dixon & M.J. Goldstein (1981). Prognosis in schizophrenia: individual differences in psychological response to a tes dose of antipsychotic drug and their relationship to blood and saliva levels and treatment outcome. Comprehensive Psychiatry 22, 147152.

D. Naber (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationship to objective psychopathology, quality of life, compliance and other clinical variables. International Clinical Psychopharmacology 10, Suppl. No. 3, 133138.

E. Simonsen & E.L. Mortensen (1990). Difficulties in translation of personality scales. Journal of Personality Disorders 4, 290296.

T. Van Putten & P.R.A. May (1978). Subjective response as a predictor of outocome in pharmacotherapy. Archives of General Psychiatry 35, 477480.

T. Van Putten , P.R.A. May , S.R. Marder & L. Wittam (1981). Subjective response to antipsychotic drugs. Archives of General Psychiatry 38, 187190.

P. Weiden , B. Rapkin , T. Mott , A. Zygmunt , D. Goldman , M. Horvitz-Lennon & A. Frances (1994). Rating of Medication Influences Scale (ROMI) in schizophrenia. Schizophrenia Bulletin 20, 297307.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology and Psychiatric Sciences
  • ISSN: 2045-7960
  • EISSN: 2045-7979
  • URL: /core/journals/epidemiology-and-psychiatric-sciences
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: